Renovacor Inc
Biotechnology
Healthcare
RCOR
17.48 M shares
NYSE MKT US
traded
30 Nov 2022
listed
yes
open
3.04
52 week high
9.39
high
3.20
52 week low
1.56
low
2.94
growth
-64.52 %
previous Close
3.05
P/E ratio
market cap
30.56 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
-4.02 M
-161.03 %
eps
0.00 %
-163.89 %
eps surprise
61.67 %
net profit margin
-402400000.00 %
0.00 %
operating incoming
-9.13 M
-3.07 %
net change in cash
-8.09 M
7.06 %
cash on hand
61.99 M
-11.54 %
cost of revenue
0.00 %
top top